Real-world Patient-reported Rates of Non-severe Hypoglycaemic Events in Germany

Abstract

Aims:

Hypoglycaemia is a common side effect of insulin therapy in diabetes patients, with negative physical and emotional impacts. Despite this, there are few studies investigating the frequency of non-severe hypoglycaemic events from the perspective of patients in the real-world setting. We investigated self-reported NSHE frequency and levels of hypoglycaemia awareness in Germany.

Methods:

Respondents>15 years with Type 1 or insulin-treated Type 2 diabetes (receiving basal only, basal-bolus or other insulin regimens) were recruited using online panels to complete≤4 questionnaires. Questionnaires collected demographics, non-severe hypoglycaemic event rates and patient-reported level of hypoglycaemia awareness. Non-severe hypoglycaemic event rates are reported as respondent-week records and calculated using data from all respondents completing at least one questionnaire.

Results:

A total of 1 771 respondent-week records were obtained from 614 participants. Mean non-severe hypoglycaemic event rates per respondent-week were 1.6 for Type 1 and 0.6–0.8 for Type 2, with estimated annual rates of 83 and 31–42 respectively. Two-thirds of Type 1 (65%) and Type 2 (61–72%) respondents reported impaired levels of awareness or unawareness of hypoglycaemic events (inability or impaired ability to recognise the symptoms of hypoglycaemia). Respon­dents’ self-reported hypoglycaemia-awareness was significantly associated with the proportion of asymptomatic non-severe hypoglycaemic events; respondents classified as being unaware of hypoglycaemia had a higher proportion of asymptomatic non-severe hypoglycaemic events than aware respondents.

Conclusion:

Non-severe hypoglycaemic events are common in people with Type 1 or insulin-treated Type 2 diabetes in the real-world setting in Germany but may still be underestimated due to an inability to recognise the symptoms of hypoglycaemia.

Key words

hypoglycaemia - insulin therapy - diabetes-related distress - hypoglycaemia awareness

• References

• 1 Rathmann W, Scheidt-Nave C, Roden M et al. Typ-2-Diabetes: Prävalenz und Relevanz angeborener und erworbener Faktoren für die Prädiktion. Deutsches Ärzteblatt 2013; 110: 331-337
• 2 CHMP . Guidelines on clinical investigation of medical products in the treatment or prevention of diabetes mellitus. http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500129256&mid=WC0b01ac058009a3dc [accessed July 2013] 2012 European Medicines Agency
• 3 ADA Workgroup on Hypoglycemia . Defining and Reporting Hypogly­cemia in Diabetes. Diabetes Care 2005; 28: 1245-1249
• 4 Davis RE, Morrissey M, Peters JR et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-1483
• 5 Donnelly LA, Morris AD, Frier BM et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755
• 6 Brod M, Christensen T, Thomsen TL et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011; 14: 665-671
• 7 Lundkvist J, Berne C, Bolinder B et al. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005; 6: 197-202
• 8 Wild D, von MR, Brohan E et al. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns 2007; 68: 10-15
• 9 Leiter LA, Yale JF, Chiasson JL et al. Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management. Canadian Journal of Diabetes 2005; 29: 1-7
• 10 IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. http://www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf [accessed July 2013] 2012
• 11 Kulzer B, Haller N, Muller UA et al. National Disease Management Guidelines. Diabetologie und Stoffwechsel 2013; 8: 107-147
• 12 UK Hypoglycaemia Study Group . Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147
• 13 Pramming S, Thorsteinsson B, Bendtson I et al. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991; 8: 217-222
• 14 Östenson CG, Geelhoed-Duijvestijn P, Lahtela J et al. Patient-reported non-severe hypoglycaemic events in Europe. Accepted for publication in Diabetic Medicine, 2013 [ ]. 2013
• 15 ESOMAR. ICC/ESOMAR International Code on Market and Social Research. http://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdf [accessed July 2013] 2007 International Chamber of Commerce ICC)
• 16 EphMRA Code of Conduct http://www.ephmra.org/professional-standards/mr-code-of-conduct.aspx [accessed July 2013]. 1997
• 17 Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-240
• 18 DCCT Research Group . Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286
• 19 UKPDS Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33). Lancet 1998; 352: 837-853
• 20 Pedersen-Bjergaard U, Pramming S, Heller SR et al. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metabolism Research and Reviews 2004; 20: 479-486
• 21 Kristensen PL, Hansen LS, Jespersen MJ et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract 2012; 96: 17-23
• 22 Akram K, Pedersen-Bjergaard U, Carstensen B et al. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006; 23: 750-756
• 23 Clarke WL, Cox DJ, Gonder-Frederick LA et al. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995; 18: 517-522
• 24 Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703
• 25 Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice. J Diabetes Complications 2010; 24: 392-397
• 26 Janssen MM, Snoek FJ, de Jongh RT et al. Biological and behavioural determinants of the frequency of mild, biochemical hypoglycaemia in patients with Type 1 diabetes on multiple insulin injection therapy. Diabetes Metab Res Rev 2000; 16: 157-163
• 27 Miller CD, Phillips LS, Ziemer DC et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001; 161: 1653-1659
• 28 Internet World Stats Internet Penetration Rates http://www.internetworldstats.com/europa2.htm [last accessed July 2013]. Usage and population statistics. 2012